Three physicians, including cancer researcher Marcelo Cerullo, MD, PhD, and two post-doctoral nurses will comprise the inaugural cohort for Duke’s National Clinician Scholars Program (NCSP). The cohort represents the first group of interdisciplinary medical researchers selected for the newly established Duke NCSP site.
Duke was identified in the spring of 2018 as the fifth location within the National Clinician Scholars Program, a consortium of prestigious academic health care research institutions that provides training for doctors and post-doctoral nurses as change agents for driving policy-relevant research and partnerships to improve health and health care.
A partnership between the Durham VA Health Care System and the Duke University schools of medicine and nursing, the Duke NCSP joined the consortium that includes UCLA, Yale University, University of Pennsylvania and the University of Michigan. The Duke Clinical and Translational Science Institute serves as the administrative home for the program at Duke.
The Duke NCSP focuses on community-based research, health services research, health policy, and implementation science across a broad range of disciplines. Scholars will build expertise in these disciplines because of the critical role they play in both improving health care access, equity, quality and outcomes, and identifying and implementing effective health care policies.
Nationally, the goal of the NCSP is to cultivate health equity, eliminate health disparities, invent new models of care, and achieve higher quality health care at lower cost by training nurse and physician researchers who work as leaders and collaborators embedded in communities, healthcare systems, government, foundations, and think tanks in the United States and around the world.
The inaugural cohort for Duke’s National Clinician Scholars Program (NCSP) includes Marcelo Cerullo, MD, MPH, whose research is specifically focused on cancer. Cerullo is interested in investigating lung cancer screening guidelines and surgical referrals, imaging in oncologic decision-making, insurance market expansion and consolidation. His research will be conducted as part of the Durham VA Health Care System’s Surgery department.